A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers

Table 5 Volunteers diaries detailing bowel habits and general mood on a daily basis throughout the study

	control bread		pre-placebo treatment		placebo treatment		post- placebo treatment		pre-AXOS treatment		AXOS treatment		post- AXOS treatment
N^o of stools	1.30	±0.72	1.33	±0.75	1.43	±0.76^b	1.44	±0.78	1.37	±0.76	1.39	±0.71	1.39	±0.79
Abdominal discomfort score *	0.11	±0.18	0.10	±0.16	0.10	±0.18	0.10	±0.17	0.13	±0.20	0.18	±0.37	0.10	±0.17
bloating score *	0.18	±0.27	0.18	±0.24	0.20	±0.27	0.17	±0.23	0.19	±0.27	0.25	±0.40	0.19	±0.23
flatulence score *	0.52	±0.53	0.47	±0.50	0.54	±0.55	0.49	±0.49	0.53	±0.53	0.51	±0.52	0.40	±0.48
Happy score **	0.01	±0.20	0.02	±0.17	0.02	±0.16	0.01	±0.18	0.01	±0.19	0.02	±0.14	0.00	±0.13
Alert **	−0.01	±0.15	−0.01	±0.09	0.03	±0.19	−0.01	±0.07	−0.01	±0.14	−0.01	±0.17	−0.01	±0.08
Energetic **	−0.07	±0.26	−0.07	±0.18	0.01	±0.14 ^b	−0.01	±0.21	−0.03	±0.25	−0.03	±0.18	−0.03	±0.13
Stressed **	0.03	±0.23	0.02	±0.15	0.05	±0.26	−0.03	±0.26	0.04	±0.24	0.07	±0.25	0.05	±0.12
Consistency ***	3.67	±0.79	3.51	±0.79	3.45	±0.77	3.54	±0.92	3.73	±0.85	3.69	±0.98	3.51	±0.85

* 0 – none, 1 – mild, 2 – moderate, 3 – severe.
** -1 – less than normal, 0 – normal, 1 – more than normal.
*** Bristol stool scale, 1 = hard, 7 = liquid.
b – significantly different to pre-treatment, (p < 0.05).
P-values of volunteer diary changes. A paired t-test was used to compare volunteer scores at different time points.

ISSN: 1475-2891